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Goedele MC Louwagie1* and Olalekan A Ayo-Yusuf1,2Abstract
Background: Tuberculosis (TB) patients who smoke tobacco are at an increased risk for adverse TB treatment
outcomes. This study describes tobacco use patterns among newly diagnosed TB patients, their readiness to quit,
and their beliefs about tobacco-related health effects in a high HIV-burden setting in South Africa. Socio-economic
and demographic factors associated with smoking were also determined.
Methods: This was a cross-sectional analysis of baseline data collected for a smoking cessation study at six large
tuberculosis clinics in a South African township (N = 1926). We collected information on current and past tobacco
use, socio-economic and demographic status, beliefs regarding the harmful effects of smoking and quit behaviour,
and motivation, using structured interviewer-administered questionnaires. TB- and HIV-related information was
obtained from patient records. Data analysis entailed descriptive statistics, followed by multivariate logistic
regression with backward elimination, adjusted for clustering by facility.
Results: Just over one fifth of respondents (21.8%, 420/1924) reported currently smoking tobacco (males 37.6%,
females 4.6%). By contrast, only 1.8% (35/1918) of all respondents reported being past smokers. Of the current
smokers, about half (51.8%, 211/407) had previously attempted to quit, mainly for health reasons. The majority of
respondents (89.3%, 1675/1875) believed tobacco smoking was harmful for their health and smokers were highly
motivated to quit (median score 9, interquartile range 7–10). Smoking was less common among female
respondents (Odds Ratio [OR] 0.10, 95% Confidence Interval [CI] 0.06-0.19) and respondents who had completed
high school (OR 0.57, 95% CI 0.39-0.84), but was more common among respondents who do occasional work
(OR 2.82, 95% CI 1.58-5.02), respondents who to bed hungry regularly (OR 4.19, 95% CI 2.42-7.25), those who have
an alcohol problem (OR 5.79, 95% CI 3.24-10.34) and those who use illicit substances (OR 10.81, 95% CI 4.62-25.3).
Conclusions: Despite documented evidence of its harmful effects, smoking is prevalent among male TB patients in
this high HIV-prevalence population. Few patients have managed to quit smoking on their own. However, patients
are highly motivated to stop smoking. We recommend implementing and evaluating a smoking cessation
programme in tandem with TB services.
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South Africa has the third highest new tuberculosis (TB)
caseload in the world, and about two thirds of TB patients
are also HIV-positive [1]. The outcomes of TB program-
mes are below the set targets, despite the widespread
introduction of standardised treatment programmes and
efforts to integrate HIV and TB services in the country
[1]. HIV is a well-established risk factor for both high TB
incidence rates and poor TB treatment outcomes, but thus
far, much less attention has been paid to the role played
by tobacco smoking in adversely affecting those outcomes
than to the role of HIV. Several systematic reviews have
found substantial evidence that tobacco smoking is asso-
ciated with an increased risk of TB infection and TB dis-
ease [2-4]. There is also some evidence (albeit less robust)
regarding the adverse effects of active smoking on TB
mortality [2-4] and on TB outcomes in patients in whom
the disease is established. Active smoking has been asso-
ciated with lower treatment adherence, slower smear con-
version, TB treatment failure, relapse and death during or
after treatment [5-11]. Furthermore, the joint effects of
smoking, TB and HIV greatly increase the risk of chronic
obstructive pulmonary disease in the long term [12]. The
introduction of smoking cessation services into TB pro-
grammes has therefore been advocated by several inter-
national bodies [13]. In response to this recommendation,
several tobacco cessation-related studies have been under-
taken in TB settings [14-16], but to our knowledge none
were conducted in countries with high HIV-TB-co-infec-
tion rates. There is therefore only limited information on
the patterns and prevalence of tobacco use in such set-
tings, and on the attitudes held by TB patients about quit-
ting. Gaining insight into these patterns and on such
prevalence could help policy-makers to identify people at
risk of the negative health outcomes of the triple burden
of tuberculosis, HIV and tobacco use, and establish
the need for cessation services as a component of TB
programmes.
This study presents the baseline data of a survey
undertaken among TB patients at primary care clinics in
South Africa for a smoking cessation study. We describe
tobacco use prevalence and patterns among this popula-
tion of patients, their readiness to quit and their beliefs
about the health effects of tobacco use. We also deter-
mined the socio-economic and demographic factors
associated with smoking.
Methods
Study design and study setting
This was a cross-sectional analysis of baseline data col-
lected from September 2011 to April 2013 in preparation
for a smoking cessation study. The study took place at the
six largest public service TB clinics in Soshanguve, a large
urban township in the City of Tshwane MetropolitanMunicipality in the Gauteng province of South Africa.
The population is predominantly black Africans. TB
clinics provide TB diagnosis and treatment and HIV-
related care. Although TB nurses do enquire about other
medical conditions and tobacco use at the time when a
person is registered as a TB patient, the nurses are not re-
quired to provide structured tobacco cessation advice to
patients.
Subjects
All adult patients seeking tuberculosis treatment at the
abovementioned clinics were asked to participate in the
study. Children (patients under 18) and patients who
had already been on treatment for over a month, very ill
patients and those unable to communicate in the local
language or in English were excluded from the study.
Measurements
Information was collected on socio-economic and demo-
graphic factors, tobacco use, alcohol and illicit substance
use, beliefs regarding the harmful effects of smoking and
exposure to second-hand smoke (SHS). Socio-economic
status was measured using questions about education, em-
ployment status, household income, an asset index (fixed
telephone, mobile phone, television, radio, refrigerator
and computer) and how often the respondent went to bed
hungry. The “CAGE” questionnaire was used to identify
respondents with possible alcohol abuse. A score of two
or more on this questionnaire is indicative of an alcohol
problem [17]. The CAGE questionnaire is a brief, easy-to-
use, validated screening tool that is widely used in clinical
settings, including in South Africa [18,19].
We inquired about both past and current tobacco
smoking, smokeless tobacco (SLT) use and exposure to
second-hand smoke (SHS). Past smokers were asked
about past quit attempts and which quitting aids they
used, if any. For current smokers, we determined the
frequency and duration of tobacco use, the age at which
the person started to smoke, the stage of change [20],
the person’s quit attempt history, confidence and mo-
tivation to quit, and beliefs about the relationship
between smoking and tuberculosis. We also inquired
about quit advice received from a health care worker
(HCW) at the last visit prior to this one. Questions
regarding tobacco use and SLT were adapted from
the Global Adult Tobacco Survey questionnaire [21].
Current smoking was defined as having smoked tobacco
in the past month. We used the brief two-item validated
version of the Fagerstrom Test for Nicotine Dependence
(“how soon after you wake up do you smoke your first
cigarette?” and “how many cigarettes do you smoke per
day?”) to measure nicotine dependence [22]. Self-
efficacy was measured with a slightly modified nine-
item short-form self-efficacy scale derived from the
Table 1 Socio-economic, demographic and clinical
characteristics of TB patients
Characteristic N n (%)








Primary schooling or less 533 (27.8)
Some high school 854 (44.5)
Completed high school or higher qualification 532 (27.7)
Marital status 1921
Now married 552 (28.7)
Divorced/separated 68 (3.5)
Never married 1225 (63.8)
Widowed 76 (4.0)
Assets
≤3 assets 1917 414 (21.6)
4 assets 1209 (63.1)
5-6 assets 294 (15.3)
Number of days hunger in past month 1920
0 days 1698 (88.4)
1-7 days 197 (10.3)
>7 days 25 (1.3)
Number of rooms in household 1918
≤3 rooms 582 (30.3)
4 rooms 606 (31.6)
5 rooms 262 (13.7)
>5 rooms 468 (24.4)
Employment status 1900
Not working* 190 (10.0)
Unemployed 666 (35.1)
Occasional work 218 (11.5)
Working full-time or part-time 826 (43.5)
Average monthly earnings in the household 1904
ZAR & 1- ZAR 500 523 (27.5)
ZAR 501-ZAR 2500 992 (52.1)
>ZAR 2500 389 (20.4)
First episode of TB 1879 1634 (87.0)
Pulmonary TB 1895 1746 (92.1)
HIV-positive** 1803 1570 (87.1)
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tive affect/social situations, negative affect situations
and habitual craving situations [23]. For SLT, we in-
quired about current and past SLT use, and type and
frequency of SLT use.
TB- and HIV-related information was extracted from
the individual patients’ records, which included informa-
tion on the site of the tuberculosis, whether this was a
first episode of TB, the patient’s HIV status and anti-
retroviral treatment.
Trained fieldworkers administered semi-structured
questionnaires to eligible patients in the local language
most commonly spoken in the study area, or in English.
The study was piloted at all six clinics over a period
of one month. The study was approved by the Ethics
Committee of the University of Pretoria (Ethics number
116/2011).
Data analysis and management
Data were double entered in Excel by trained full-time
data capturers and exported into STATA version 12 for
data comparison, cleaning and analysis [24]. Cronbach
alpha internal consistency coefficients were calculated
for the scales. The descriptive summary statistics con-
sisted of percentages for categorical variables, and means
with standard deviations or medians with interquartile
ranges, as appropriate. The characteristics of current
smokers vs. those of non-smokers were compared first,
using χ2-tests. This analysis was followed by multivariate
logistic regression with the use of backward elimination,
with liberal retention criteria for non-predictive models
(p < 0.2) [25]. Co-variates known to be associated with
smoking from the literature review and those identified
during the univariate analysis at the 25% level were
included in the original multivariate model, in addition
to interaction terms. Standard errors of results were
adjusted for clustering by facility.
Results
Of the 2411 patients screened, 428 (17.8%) were ex-
cluded from the interviews (247 were children, 121 were
too ill or unable to understand the interview language,
49 had had more than one month of TB treatment, and
11 were excluded for other reasons). Nearly all (97.2%,
1926/1983) eligible patients gave their consent to partici-
pate in the study.
The baseline characteristics are presented in Table 1.
Just over half of the patients were male (52.3%), and
nearly 60% were between 18 and 39 years old. Just over
a quarter of the patients (27.7%) had completed high
school or had a higher qualification, and close to two-
thirds had never been married (63.8%). Many respon-
dents were poor: 79.6% lived in households with total
earnings of less than ZAR 2500 per month (about 287
Table 1 Socio-economic, demographic and clinical
characteristics of TB patients (Continued)




Alcohol problem 1895 367 (19.4)
Illicit drug use 1882 77 (4.1)
*Retired/unable to work/house-maker/student/other; &ZAR = South African
Rand; 8.7 ZAR ≈ 1 US dollar; **HIV status unknown for 123 patients.






Age started smoking (N = 327)







Number of cigarettes per day (daily smokers, N = 352)
Tobacco dependent& (daily smokers)
Current SLT† use
Uses snuff by mouth (current SLT user)**
Uses snuff by nose (current SLT user)**







*SHS = second-hand smoke; **each item is a separate question, therefore patients m
for daily cigarette smokers ≥ 4; †SLT = smokeless tobacco.
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dwelling with three rooms or fewer, 21.6% owned only
three of the listed assets or fewer, and 11.6% went to bed
hungry at least one day per month.
In terms of clinical characteristics, 87.0% of patients
presented with a first episode of TB, and 92.0% had pul-
monary TB. Nearly 90% of patients who knew their HIV
status were HIV-positive (87.1%), but fewer than a
quarter of these had records of undergoing antiretroviral
treatment (22.9%) (Table 1).
Just over one fifth of patients reported current tobacco
smoking (18.8% daily smokers and 3.1% occasional
smokers). This figure was much higher for men (37.6%),
than for women (4.6%). Very few of the total group of
respondents (1.8%) were past smokers (in other words,
had successfully quit smoking in the past). WhenAll patients Male Female
n (%) n (%) n (%)
Mean (SD) Mean (SD) Mean (SD)
Median (IQR) Median (IQR) Median (IQR)
420/1924 (21.8) 378/1005 (37.6) 42/919 (4.6)
361 (18.8) 328 (32.6) 33 (3.6)
59 (3.1) 50 (5.0) 9 (1.0)
35/1918 (1.8) 30/1004 (3.0) 5/914 (0.6)
18.5 (SD 5.6) 18.3 (SD 5.7) 19.7 (SD 4.8)
21.6 (SD 10.7) 21.9 (SD 10.4) 19.3 (SD 13.0)
412/415 (99.3) 371/374 (99.2) 41/41 (100)
52/413 (12.6) 48/372 (12.9) 4/41 (9.8)
2/412 (0.5) 2/371 (0.5) 0/41 (0.0)
1/413 (0.2) 1/371 (0.3) 0/41 (0.0)
0/410 (0) 0/371 (0.0) 0/41 (0.0)
9.8 (SD 7.0) 9.8 (SD 7.0) 10.0 (SD 7.3)
8 (5–12.5) 8 (5–12.0) 6.5 (4–17.5)
74/326 (22.7) 65/297 (21.9) 9/29 (31.0)
76/1920 (4.0) 11/1005 (1.1) 65/915 (7.1)
28/69 (40.6) 2/8 (25.0) 26/61 (42.6)
47/67 (70.2) 7/7 (100) 40/60 (66.7)
224/1479 (15.2) 68/612 (11.1) 156/867 (18.0)
170/1478 (11.5) 98/612 (16.0) 72/866 (8.3)
174/1479 (11.8) 59/612 (9.6) 115/867 (13.3)
140/1479 (9.5) 57/612 (9.3) 83/867 (9.6)
174/1479 (11.8) 52/612 (8.5) 122/867 (14.1)
169/1477 (11.4) 58/611 (9.5) 111/866 (12.8)
ay have responded yes to several questions; &2-item brief dependency score
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rose marginally to 2.3% (not presented in table). The
mean age of smoking initiation was 18.5 (Standard Devi-
ation [SD] 5.6) years. Daily smokers smoked an average of
9.8 (SD 7.0) cigarettes per day. About one fifth of the daily
smokers (22.7%) were nicotine-dependent (they had a
two-item brief nicotine dependency score ≥4) (Table 2).Table 3 Quit behaviour and attitudes among smokers and HC
Variable
Current smokers (N = 420)
Quit attempt in the past 12 months (all current smokers)
Duration of quit attempt in days (smokers who attempted to quit)






Switching to smokeless tobacco
Other
Main reason for trying to quit in the past (smokers who attempted to quit
Too expensive
Health reasons
Other (addictive, bad example, smell, not fair to others)
Stage of change (all current smokers)
Not intending to quit smoking
Considering quitting smoking in the next 6 months
Seriously thinking about quitting in the next 30 days
Motivation score (one item 1–10) (all current smokers)
Confidence score (one item 1–10) (all current smokers)
Perceived self-efficacy score (9 items, 9–45) (all current smokers)$
HCW assessed smoking status at last health visit
Advice received from HCW at last visit (all patients for whom smoking stat
No advice
Advised to stop smoking completely
Advised to cut down on smoking
Past smokers (N = 35)
Age at starting tobacco smoking (past smokers)
Duration of smoking in years (past smokers)
Quit duration in months (past smokers)
Smoking cessation aids and services used (past smokers)**
Counselling
Nicotine replacement therapy, other prescription medication, traditiona
*HCW = Health care worker; **each item is separate question, therefore patients ma
not add up to exactly 100% due to rounding off errors; $Cronbach alpha for efficacOf the respondents, 4.0% confirmed currently using
SLT (women 7.1%; men 1.1%). The most common form
of SLT use was snuff by nose (70.2% of SLT users). Be-
tween 11% and 15% of all non-smokers reported being
exposed to SHS for seven or more days per month at
home, at the workplace and in a number of other set-






























22 19.4 (SD 3.8)
24 17.6 (SD 10.7)
32 5 (2–11.5)
32 3 (0.4)
l medicine, quit line, SLT 32 0 (0.0)
y have responded yes to several questions; &some column percentages may
y score = 0.92.
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stated that they had attempted to quit in the past
12 months (median quit duration: 21 days). However,
very few patients had made use of cessation aids or ser-
vices. The respondents cited their health as their main
reason for wanting to quit (70.7%). Respondents ap-
peared to be highly motivated to quit (median score 9,
Interquartile Range [IQR] 7-10) and were confident that
they could do so (median score 9, IQR 6–10), and 58.3%
reported that they were in the preparation stage. The
perceived self-efficacy score was, however, somewhat
lower (median 25, IQR 17–36). Past smokers had, on
average, quit about five months ago (median 5, IQR
2–11.5) and had done so mostly without the help of ces-
sation aids (Table 3). Over two thirds of current smokers
(67.3%) were asked whether they were smoking when
they had last had contact with a HCW. Of these, 71.6%
were advised to stop smoking completely and 13.8% to
cut down on smoking (Table 3).
Respondents had a high awareness of the health risks
of tobacco smoking. This knowledge was particularly
good with regard to the risk of lung cancer (90.5%).
However, knowledge regarding the risk of stroke and
heart attack was lower, with only 48.5% of the patients
indicating that smoking causes heart attacks and 38.2%
that smoking causes strokes. Although the beliefs of
smokers and non-smokers differed on the individual
questions, there were no significant trends. Overall, the
health risk belief score was slightly higher for smokersTable 4 Health beliefs of TB patients regarding the harmful e
n/N (%)
Smoking causes serious illness
No 106/1875 (5.7)




Don’t know 866/1886 (45.9)
Yes 720/1886 (38.2)
Smoking causes heart attack
No 280/1889 (14.8)
Don’t know 692/1889 (36.6)
Yes 917/1889 (48.5)
Smoking causes lung cancer
No 42/1889 (2.2)
Don’t know 138/1889 (7.3)
Yes 1709/1889 (90.5)
Health belief score** 7 (7–9)
*Non-parametric test for trend; **3 questions about stroke, heart attack and lung ca
rank sum test.than for non-smokers (p = 0.036) (Table 4). Questions
regarding the relationship between smoking and tuber-
culosis were posed only to current smokers. Of the res-
pondents, about 40% mentioned without prompting that
smokers were more likely to get TB, and a third men-
tioned that smoking worsens TB. These figures rose to
over 80% when respondents were prompted to answer
individual questions about specific adverse effects of
smoking on TB (Table 5).
The socio-economic and demographic factors that we
found to be independently associated with smoking are
presented in Table 6. Current smoking was much less
common in women (OR 0.10, 95% CI 0.06-0.19), in res-
pondents who had completed high school or had higher
qualifications (OR 0.57, 95% CI 0.39-0.84), and in those
living in houses with more than five rooms (OR 0.65, 95%
CI 0.46-0.92). Current smoking was more common in res-
pondents who were doing occasional work (OR 2.82, 95%
CI 1.58-5.02), those who went to bed hungry for more
than seven days a month (OR 4.19, 95% CI 2.42-7.25),
those who had an alcohol problem (OR 5.79, 95% CI 3.24-
10.34) and those who used illicit substances (OR 10.81,
95% CI 4.62-25.3). There was no interaction between sex
and socio-economic indicators, sex and an alcohol pro-
blem, or drug use and an alcohol problem.
Discussion
About one in five TB patients in our study were identi-
fied as current tobacco smokers, a figure that is veryffects of smoking
Current smoker Non-smoker P-value*
30/406 (7.4) 76/1467 (5.2) 0.991
28/406 (6.9) 66/1467 (4.5)
348/406 (85.7) 1325/1467 (90.3)
51/406 (12.6) 249/1478 (16.9) 0.281
175/406 (43.1) 690/1478 (46.7)
180/406 (44.3) 539/1478 (36.5)
53/408 (13.0) 227/1479 (15.4) 0.679
143/408 (35.1) 548/1479 (37.1)
212/408 (52.0) 704/1479 (47.6)
6/408 (1.5) 36/1479 (2.4) 0.798
41/408 (10.1) 97/1479 (6.6)
361/408 (88.5) 1346/1479 (91.0)
8 (7–9) 7 (7–9) 0.036 &
ncer, score range 3–9; Cronbach alpha for health belief score = 0.60; &Wilcoxon
Table 5 Perceived relationship between smoking and TB among current smokers*
No Don’t know Yes
n (%) n (%) n (%)
Perceived relationship between smoking and TB (not prompted) (N = 420)
A smoker is more likely to get TB N/A** N/A 165 (39.3)
Smoking causes TB to become worse N/A N/A 143 (34.1)
Smoking makes TB treatment not to work as well N/A N/A 94 (22.4)
Smoking causes TB to relapse N/A N/A 48 (11.4)
Smokers with TB are more likely to die of TB than non-smokers N/A N/A 34 (8.1)
Other N/A N/A 12 (2.9)
Perceived relationship between smoking and TB (prompted) (N varies between 395 and 400)
A smoker is more likely to get TB 29 (7.3) 29 (7.3) 340 (85.4)
Smoking causes TB to become worse 39 (9.8) 31 (7.8) 330 (82.5)
Smoking makes TB treatment not to work as well 59 (14.8) 42 (10.6) 297 (74.6)
Smoking causes TB to relapse 51 (12.9) 46 (11.7) 298 (75.4)
Smokers with TB are more likely to die of TB than non-smokers 47 (11.8) 47 (11.8) 303 (76.3)
TB smoking belief score (median [IQR])& 15 (12–15)
*Questions courtesy of Professor M. Nichter, University of Arizona; **N/A = not applicable; &5 items, score range 5–15, Cronbach alpha for TB smoking
belief score = 0.85.
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in South Africa [26]. Our male and female smoking preva-
lence rates were also similar to those of black urban South
Africans in the 2003 South African Demographic and
Health Survey (SADHS) [27]. Our smoking rates were,
however, much lower than those of a recent study in Cape
Town, in which 56% of patients with active TB were iden-
tified as current smokers [28]. Plausible explanations for
this large difference in smoking rates could be that there
were more males, and more participants of ‘mixed
ancestry’ in the Cape Town study, two groups which a
prior study has shown to smoke more commonly [27].
HIV prevalence rates were also much higher in our study
than in the Cape Town study. It may be that the effect of
smoking on TB incidence is masked by the overwhelming
influence of the HIV epidemic in our study setting. In
addition, we may have had more under-reporting of smo-
king, because cotinine testing was not performed in our
study, whereas it was done in the Cape Town study.
A high percentage of smokers indicated that they
intended to quit. Half had already tried to quit in the
past. These findings are comparable to the results of a
small survey among 150 HIV-positive smokers attending
HIV clinics in South Africa [29]. Similarly, 41% of TB
patients in a Malaysian study had ever tried to quit and
40% were in the preparation stage of quitting [16]. How-
ever, only about 2% of all the participants in our study
reported actually succeeding in quitting, a figure much
lower than the 9.4% quitters in a group of black Africans
in a 2002 countrywide survey [30]. The difference in quitrates suggests that the studied population might find it
more difficult to quit than the general population.
Nearly 70% of the TB patients reported being screened
for tobacco smoking at their last health care visit prior to
this one, and 85% of the identified smokers were advised
to stop smoking or to reduce their smoking. These figures
were much higher than those reported on exit interviews
at a community health centre in the same province in
patients with a range of medical conditions: in these exit
interviews, it was found that only 12.9% of patients were
screened and only 11.9% of smokers were advised to quit
[31]. This large difference can possibly be attributed to the
fact that TB patients present with a cough, prompting
HCWs to inquire about smoking. Another explanation is
an increased awareness of the dangers of smoking among
TB clinic nurses as a result of information received about
the implementation of a tobacco cessation study at the
study sites. The high percentage of patients who reported
that they believe smoking is harmful for health is in kee-
ping with high perceived current and future health risks of
smoking reported in a study on HIV-positive smokers in
South Africa [29].
Age, sex and marital status distribution and marital
status in our respondents were similar to those reported
in a recent large South African study among TB patients
in South Africa [26]. Smoking was demonstrably asso-
ciated with being male, having a lower level of education
and lower income, which is in keeping with findings
of smoking patterns in general non-TB populations
in South Africa and other countries [27,30,32]. Not
Table 6 Demographic and socio-economic factors






n/N (row %) (95% CI)**
Sex
Male 378/1005 (37.6) 1
Female 42/919 (4.6) 0.10 (0.06-0.19) <0.001
Age groups
18-29 years 55/409 (13.5) 1
30-39 years 144/712 (20.2) 1.34 (0.89-2.02) 0.167
40-49 years 145/502 (28.9) 1.66 (1.04-2.65) 0.035
50-59 years 58/216 (26.9) 1.42 (0.80-2.51) 0.230





Some high school 198/852 (23.2) 0.88 (0.59-1.32) 0.537
Completed high
school or higher




ZAR#1- ZAR500 143/522 (27.4) 1
ZAR501- ZAR2500 207/991 (20.9) 0.89 (0.60-1.32) 0.575
>ZAR 2500 64/389 (16.5) 0.67 (0.36-1.27) 0.223 &
Employment status
Not working 24/190 (12.6) 1
Unemployed 118/665 (17.7) 1.58 (0.89-2.79) 0.115
Occasional work 80/218 (36.7) 2.82 (1.58-5.02) <0.001
Working full-time
or part-time
189/825 (22.9) 1.58 (0.76-3.30) 0.220
Assets
≤3 assets 116/412 (28.2) Not retained
4 assets 248/1209 (20.5) in model
5-6 assets 51/294 (17.4)
Number of days hunger
in past month
0 days 351/1696 (20.7) 1
1-7 days 54/197 (27.4) 1.18 (0.81-1.71) 0.396
>7 days 11/25 (44.0) 4.19 (2.42-7.25) <0.001
Number of rooms
≤ 3 rooms 155/582 (26.6) 1
4 rooms 134/604 (22.2) 0.98 (0.78-1.24) 0.856
5 rooms 50/262 (19.1) 0.75 (0.44-1.28) 0.291
>5 rooms 77/468 (16.5) 0.65 (0.46-0.92) 0.014
Table 6 Demographic and socio-economic factors
associated with current smoking* (Continued)
Alcohol problem
No 207/1526 (13.6) 1
Yes 203/367 (55.3) 5.79 (3.24-10.34) <0.001
Drug use
No 347/1804 (19.2) 1
Yes 60/76 (79.0) 10.81 (4.62-25.30) <0.001
*Variables entered in original model: sex, age category, drug use, alcohol
problem, education level, hunger, number of rooms, household income,
assets, employment category, interaction sex*education, sex*household
income, sex*employment category, drug use*alcohol problem, sex*alcohol
problem. Pearson Goodness of fit p-value = 0.15;**Robust standard errors;
&p-value <0.20 in model before adjustment for clustering, therefore retained in
model, #ZAR = South African Rand.
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smoking were often found to occur concurrently [33].
These findings indicate a need to address addictive
behaviours simultaneously, especially because alcohol
dependence may affect quit rates adversely [33,34].
Our study has a number of limitations. First, the popu-
lation of TB patients is not representative of all TB pa-
tients in the province concerned (Gauteng) or the country
(South Africa) and results can therefore not be gene-
ralised. Nearly one fifth of the patients were excluded be-
cause of non-eligibility, mainly because they were younger
than 18 years. Other reasons included that some patients
were so severely ill that they could not participate and that
there were communication problems due to language
differences (South Africa has 11 official languages and a
number of other languages, and immigrants also attend
the facilities). We also did not collect socio-demographic
or smoking-related information on these patients to
demonstrate comparability with study participants. This
may have introduced some bias in the prevalence esti-
mates for adults, and implies that the results cannot be
applied to children. Moreover, it is possible that current
smoking status was underreported, since we did not bio-
logically validate self-reported smoking rates. Recent
smoking cessation may have introduced a “sick quitter”
bias, but this is unlikely to be significant, as past smoking
rates were very low. As is common with questionnaires,
desirable behaviours and beliefs may have been over-
reported.
Conclusions
In conclusion, our study demonstrates relatively high
current smoking rates, in particular among male TB
patients, despite the potential adverse effects of conti-
nued smoking on both TB- and HIV-related treatment
outcomes. Many of the current smokers appeared to be
highly motivated to stop smoking, and both smokers
and non-smokers strongly believed smoking was harmful
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http://www.biomedcentral.com/1471-2458/13/1031to their health. There was also some evidence of promi-
sing smoking screening practices among HCWs. How-
ever, the low past smoking rates in the total group of
study participants are an indication that it may be dif-
ficult to succeed in quitting without assistance.
In view of these findings, we recommend the imple-
mentation and evaluation of a formal tobacco cessation
programme in TB and HIV services. Smokers identified
from this study were enrolled in a smoking cessation trial
immediately after the administration of the baseline ques-
tionnaires. This follow-up study aims to evaluate the
effectiveness of motivational interviewing by lay HCWs to
assist TB patients to stop smoking tobacco. If the trial is
found to be effective, lay HCWs could in future deliver
smoking cessation counselling in addition to providing
preventative, curative and other support functions. Such
an approach would fit in with the plans to introduce
community-based health outreach teams, as envisaged by
the Department of Health in South Africa [35] and free up
nurses’ working time to focus on the complex management
of TB patients who are often dually infected with HIV.
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